$0.46
0.005[1.10%]
At close: Apr 22
$0.46
0[0.00%]
After Hours: 4:01PM EDT
Evoke Pharma
(NASDAQ:EVOK)Latest News for Evoke Pharma Stock (NASDAQ:EVOK)
Evoke Pharma Stock (NASDAQ: EVOK)
Categories: All
Thursday, March 21, 2024
Thursday, March 14, 2024
- Evoke Pharma Sees FY24 Net Revenue ~$14M Vs $14.017M Est.Benzinga Newsdesk - Mar 14, 2024, 4:50PM
- Recap: Evoke Pharma Q4 EarningsBenzinga Insights - Mar 14, 2024, 4:35PM
- Evoke Pharma Q4 2023 GAAP EPS $(0.59) Misses $(0.50) Estimate, Sales $1.676M Beat $1.632M EstimateBenzinga Newsdesk - Mar 14, 2024, 4:31PM
- Earnings Scheduled For March 14, 2024Benzinga Insights - Mar 14, 2024, 5:52AM
Wednesday, March 13, 2024
Friday, February 09, 2024
- 12 Health Care Stocks Moving In Friday's Pre-Market SessionBenzinga Insights - Feb 9, 2024, 8:06AM
- Evoke Pharma Has Priced An Underwritten Public Offering Led By Nantahala Capital Management For Gross Proceeds Of Up To $30M Million, Which Includes Initial Upfront Funding Of Approximately $7.5MBenzinga Newsdesk - Feb 9, 2024, 7:33AM
Tuesday, January 23, 2024
Tuesday, January 16, 2024
Monday, January 15, 2024
Friday, January 12, 2024
Thursday, January 11, 2024
Monday, November 27, 2023
Friday, November 24, 2023
Tuesday, November 14, 2023
Thursday, November 09, 2023
Friday, September 29, 2023
Thursday, September 14, 2023
- 12 Health Care Stocks Moving In Thursday's Pre-Market SessionBenzinga Insights - Sep 14, 2023, 9:06AM
- Evoke Pharma Has Been Granted A Notice Of Allowance From The U.S. Patent And Trademark Office For Patent Application Pertaining To Gimoti, FDA-Approved Nasal Formulation Of Metoclopramide; The Patent Will Cover The Intranasal Pharmaceutical CompositionBenzinga Newsdesk - Sep 14, 2023, 8:40AM